The article discusses the initial steps to adopt a zero trust architecture for businesses, ensuring it aligns with their specific requirements. It emphasizes understanding the architecture, defining the company’s unique trust criteria, mapping out the architecture’s implementation across the network, and regularly reviewing and adjusting the approach.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
